Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer Metastasis
Anticancer Research · 2025
DOI: 10.21873/anticanres.17720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, 2025. Verfasst von Mai Hazekawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Delivery, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka, Japan; mhaze@fukuoka-u.ac.jp. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms, Drug Delivery Systems, Nucleic Acids.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Delivery, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka, Japan; mhaze@fukuoka-u.ac.jp.
- Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka, Japan.
Zitieren
APA
Hazekawa, M., Nishinakagawa, T., & Ishibashi, D. (2025). Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer Metastasis. Anticancer Research. https://doi.org/10.21873/anticanres.17720
Vancouver
Hazekawa M, Nishinakagawa T, Ishibashi D. Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer Metastasis. Anticancer Research. 2025. doi:10.21873/anticanres.17720
BibTeX
@article{Hazekawa2025,
author = {Hazekawa, Mai and Nishinakagawa, Takuya and Ishibashi, Daisuke},
title = {Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer Metastasis},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17720}
}
EUVIMED